Results 71 to 80 of about 984 (118)

Programmare e ripartire alle Aziende Sanitarie le risorse per la farmaceutica: una proposta dal Forum Politiche Farmaceutiche Regionali. [PDF]

Glob Reg Health Technol Assess
Jommi C, Rebesco B, Perrone F, Amodeo R, Bortolami A.   +4 more
europepmc   +1 more source

Protein-lipid Association in Lizard Chemical Signals. [PDF]

Integr Org Biol, 2023
Mangiacotti M, Baeckens S, Fumagalli M, Martín J, Scali S, Sacchi R.   +5 more
europepmc   +1 more source

Neuroinflammation in CTLA-4 Haploinsufficiency: Case Report of a New Variant with Remarkable Response to Targeted Therapy. [PDF]

Int J Mol Sci
Baldini L, Del Vecchio L, Cerasi S, Fetta A, Moratti M, Bezzi A, Ferrari S, Di Dalmazi G, Rossi S, Toni F, Cordelli DM, Lanari M, Conti F.   +12 more
europepmc   +1 more source

MOG IgG3-Subclass Antibodies in MOG-Associated Disease: Insights From a Pediatric Case With IgG1 Deficiency and Literature Review. [PDF]

Neurol Neuroimmunol Neuroinflamm
Fetta A, Conti F, Lopalco A, Corsini C, Moratti M, Morelli L, Ricciardiello F, Toni F, Lanari M, Liguori R, Cordelli DM, Giannoccaro MP.   +11 more
europepmc   +1 more source

The trickle down from environmental innovation to productive complexity. [PDF]

Sci Rep, 2022
de Cunzo F, Petri A, Zaccaria A, Sbardella A.   +3 more
europepmc   +1 more source

C(nn) e uso compassionevole: due approcci per l’early access. Proposte per una migliore gestione. [PDF]

Glob Reg Health Technol Assess
Bortolami A, Marzona I, Stella P, Acciai V, Ladisa V, Medaglia M.   +5 more
europepmc   +1 more source

Correction: Olfactory bulb anomalies in KBG syndrome mouse model and patients. [PDF]

BMC Med
Goodkey K, Wischmeijer A, Perrin L, Watson AES, Qureshi L, Cordelli DM, Toni F, Gnazzo M, Benedicenti F, Elmaleh-Berges M, Low KJ, Voronova A.   +11 more
europepmc   +1 more source

Prediction and visualization of Mergers and Acquisitions using Economic Complexity. [PDF]

PLoS One, 2023
Arsini L, Straccamore M, Zaccaria A.
europepmc   +1 more source

La durata delle procedure di negoziazione di prezzo e rimborso in Italia nel periodo 2021-2023 è stata indipendente dal prezzo dei medicinali. [PDF]

Glob Reg Health Technol Assess
Cocciolo R, Turella P, Pilunni D, Navarra P.   +3 more
europepmc   +1 more source